Press release
Cannabinoi*d Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | The Supreme Cannabi*s Company Inc., Elixinol Global Limited, GW Pharmaceuticals PLC., Tilray Inc
Cannabinoi*ds Market Characteristics
The Business Research Company offers in-depth market insights through Cannabinoi*d Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The cannabinoi*d market size has grown exponentially in recent years. It will grow from $33.1 billion in 2023 to $39.86 billion in 2024 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to medical cannabi*s legalization, increasing acceptance of cannabi*s, research and development, regulatory changes, growing awareness of cannabinoi*d benefits, investments in cannabi*s industry, consumer trends toward natural products..
The cannabinoi*d market size is expected to see exponential growth in the next few years. It will grow to $84.38 billion in 2028 at a compound annual growth rate (CAGR) of 20.6%. The growth in the forecast period can be attributed to wider legalization and decriminalization, research advancements, diverse product offerings, international market expansion, public health awareness initiatives.. Major trends in the forecast period include increasing acceptance and destigmatization, diversification of product offerings, innovation in delivery methods, quality and safety standards, social equity and inclusivity initiatives..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8079&type=smp
Market Segmentation:
The cannabinoi*d market covered in this report is segmented -
1) By Product Type: Cannabidio*l, Tetrahydrocannabinol, Cannabinol, Other Product Types
2) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Stores
3) By Application: Medical, Recreational, Industrial Hemp
Major Driver - Cannabinoi*d Market Surges Amidst Rising Prevalence Of Chronic Diseases
The rising prevalence of chronic diseases is expected to propel the cannabinoi*d market. Chronic diseases refer to illnesses that last a year or longer and require ongoing medical attention. The effectiveness of cannabinoi*d, such as smoked marijuana, oromucosal extracts of cannabi*s-based medication, nabilone, dronabinol, and a new TH*C analogue, in the treatment of chronic noncancer pain, was examined in a systematic review of randomized controlled trials. For instance, according to the McKinsey report, it is anticipated that the US illness burden will rise by almost 20% through 2040. Furthermore, according to the Center for Disease Control and Prevention, six in ten Americans live with at least one chronic disease. As a result, the rising prevalence of chronic diseases is driving the growth of the cannabinoi*d market.
Competitive Landscape:
Major companies operating in the cannabinoi*d market report are The Supreme Cannabi*s Company Inc., Elixinol Global Limited, GW Pharmaceuticals PLC., Tilray Inc., Aurora Cannabi*s Inc., Innovative Ind Props, Curaleaf Holdings Inc., Green Thumb Industries, Verano Holdings, Trulieve Cannabi*s Corp., Cresco Labs Inc., Cronos Group, TerrAscend Corp., Canopy Growth Corp., Sundial Growers Inc., Decibel Cannabi*s Company, Auxly Cannabi*s Group, Red White & Bloom Brands, BZAM Ltd, Delta 9 Cannabi*s Inc., Mylan N.V., Westleaf Cannabi*s Inc., GrowGeneration, The Scotts Miracle-Gro Company, Jazz Pharmaceuticals plc, Aphria Inc., Organigram Inc., Alkem labs, MediPharm Labs Corp., The Valens GroWorks Inc.
Get Access To The Full Market Report -
http://surl.li/riqco
Top Trend - Innovative Cannabi*s-Based Cosmetics Revolutionize Cannabinoi*d Market Competition
Major companies operating in the cannabinoi*d market are focused on introducing advanced cannabi*s-based cosmetic solutions, such as CBG and CB*D rescue cream, to gain a competitive edge in the market. Cannabi*s-based cosmetic solutions are cosmetic products that contain cannabi*s or its derivatives, such as CB*D or CBG, as an active ingredient. These products are used in the cosmetic industry for various purposes, such as skin moisturizing, anti-aging, and anti-inflammatory effects. For instance, in November 2022, British Cannabi*s, a UK-based producer of cannabi*s, launched the Synergy CBG and CB*D Rescue Cream. It is the UK's first cannabi*s cosmetic to undertake clinical trials, and it is now all the better from having an extra-active ingredient, CBG, in its formula. Together with two natural, legal cannabi*s plant extracts, cannabidio*l (CB*D) and cannabigerol (CBG), Synergy CB*D Rescue Cream is a gentle, natural cream that makes up one of the most comprehensive skin care products on the market.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Cannabinoi*d Market Characteristics
3. Cannabinoi*d Market Trends And Strategies
4. Cannabinoi*d Market - Macro Economic Scenario
5. Cannabinoi*d Market Size And Growth
…..
27. Cannabinoi*d Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Health*care Blog: https://http://surl.li/riqfb
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, health*care, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cannabinoi*d Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | The Supreme Cannabi*s Company Inc., Elixinol Global Limited, GW Pharmaceuticals PLC., Tilray Inc here
News-ID: 3418533 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cannabinoi*d
Don't Panic, Exit Safely: D&D Hardware's Advanced Devices Are Changing The Game
When alarms sound, smoke rises, and crowds push toward the exits, the path to safety depends on one crucial detail: whether the door hardware will perform flawlessly under pressure. Panic and fire exit devices are not simply pieces of metal fixed to a door-they are life-saving mechanisms. As a prominent Leading Panic Hardware Exporter from China(https://www.danddhardware.com/door-push-bars.html), D&D Hardware is acutely aware of this responsibility. We engineer our advanced exit devices…
GLP-1 Market Key Players Analysis - AstraZeneca, Biolingus, Boehringer Ingelheim …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global GLP-1 Market Size, Share & Trends Analysis Report By Type of Molecule (Biologics and Small Molecules), Active Compound Used (Dulaglutide, Liraglutide, Orforglipron, Retatrutide, Semaglutide, Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist), Route of Administration (Oral and Parenteral),…
GLP-1 Market Top Players - AstraZeneca, Biolingus, Boehringer Ingelheim, D&D Pha …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global GLP-1 Market Size, Share & Trends Analysis Report By Type of Molecule (Biologics and Small Molecules), Active Compound Used (Dulaglutide, Liraglutide, Orforglipron, Retatrutide, Semaglutide, Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist), Route of Administration (Oral and Parenteral),…
Prominent Cannabigerol (CBG) Gummie*s Market Trend for 2025: Meeting Wellness De …
What Are the Projected Growth and Market Size Trends for the Cannabigerol (CBG) gummie*s Market?
The market for cannabigerol (CBG) gummie*s has seen a significant increase in size over the past few years. The market is predicted to rise from $2.03 billion in 2024 up to $2.96 billion in 2025, reflecting a compound annual growth rate (CAGR) of 45.8%. The expansion observed in the historical period is primarily due to factors…
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market.
Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196
The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Sanitized Approach to Drive the Cannabinoi Biosynthesis Market
According to the latest research by Persistence Market Research, the Cannabinoi Biosynthesis Market is set to witness growth at 15.5% rate during 2021-2031. Demand for cannabinoi biosynthesis market is expected to see positive maturation due to recreational and medical use of this addictive medicine is gaining increased legalization across the globe.
With this various medical applications are gaining ground. The environmental impact of the natural extraction of cannabinois from cannabi plants…
